List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 245 studies with search of:   Estonia
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Postmenopausal Evaluation and Risk-Reduction With Lasofoxifene (PEARL)
Condition: Osteoporosis
Interventions: Drug: lasofoxifene;   Other: placebo;   Drug: lasofoxifene
2 Recruiting Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem
Condition: Infection
Interventions: Drug: Avelox (Moxifloxacin, BAY12-8039);   Drug: Ertapenem intravenous
3 Recruiting A Double-Blind, Placebo-Controlled, 2-Year Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease.
Conditions: Dementia, Alzheimer Type;   Alzheimer Disease
Interventions: Drug: Galantamine;   Drug: Placebo
4 Terminated GALLANT 22 Tesaglitazar vs. Placebo
Condition: Type 2 Diabetes
Interventions: Drug: Tesaglitazar;   Behavioral: Dietary and Lifestyle counseling
5 Terminated G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)
Condition: Type 2 Diabetes
Intervention:
6 Completed SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Tiotropium bromide 18mcg;   Drug: Fluticasone propionate/ salmeterol combination 50/500mcg
7 Active, not recruiting RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes
Condition: Type II Diabetes
Interventions: Drug: rosiglitazone;   Drug: metformin;   Drug: sulfonylurea
8 Completed Study of Aripiprazole in Patients With Bipolar I Disorder
Condition: Bipolar Disorder
Intervention: Drug: aripiprazole
9 Completed Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia
Condition: Community Acquired Pneumonia
Interventions: Drug: NXL103;   Drug: comparator;   Drug: NXL103
10 Recruiting Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Condition: Influenza Disease
Interventions: Biological: GSK Bio's influenza vaccine GSK2186877A;   Biological: Fluarix
11 Terminated GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Drug: tesaglitazar
12 Completed Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of Life
Conditions: Osteoarthritis;   Rheumatoid Arthritis
Intervention:
13 Completed JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events
Condition: Elevated hs C-Reactive Protein
Intervention: Drug: Rosuvastatin
14 Active, not recruiting Zolip 0502: Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
Condition: Cardiovascular Diseases
Interventions: Drug: Fenofibrate/Simvastatin;   Drug: Simvastatin
15 Recruiting [S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy.
Condition: Pain
Interventions: Drug: [S,S]-Reboxetine;   Drug: Any
16 Active, not recruiting Benign Prostatic Hyperplasia Trial With AVODART And Tamsulosin Combination Treatment
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: AVODART;   Drug: Tamsulosin
17 Completed Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes
Intervention: Drug: Insulin sensitizer
18 Active, not recruiting Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)
Condition: Asthma
Interventions: Drug: Mometasone furoate/formoterol (MF/F) combination;   Drug: Fluticasone propionate and salmeterol (F/SC) DPI
19 Recruiting Dexmedetomidine Versus Midazolam for Continuous Sedation in the Intensive Care Unit (ICU)
Condition: Continuous Sedation in Initially Sedated Adults in ICU
Interventions: Drug: Dexmedetomidine;   Drug: Midazolam
20 Active, not recruiting Efficacy and Safety Study of TAK-491 Compared to Ramipril for Treating Essential Hypertension
Condition: Essential Hypertension
Interventions: Drug: TAK-491;   Drug: TAK-491;   Drug: Ramipril

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services